Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin Treatment of Alcohol Dependence
NCT02275611Phase 2Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Jan 2013
- Primary completion
- Dec 2013
01
Overview
A Phase 2 trial of oxytocin nasal spray in alcohol dependence, alcohol withdrawal syndrome (AWS), sponsored by University of North Carolina at Chapel Hill. Started Jan 2013; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
alcohol dependencealcohol withdrawal syndrome (AWS)
Beyond the preview
Go deeper on NCT02275611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02275611.